About Quetiapine Fumarate API

Therapeutic CategorySistema Nervioso Central (SNC)
API Technology
Synthetic
Dose Form
Oral Solid/Tablets
Dr Reddy's Development Status
Available (Commercial)
Available Regulatory Filing
USDMF, CEP Submitted, Brazil DMF, EUDMF, Canada DMF, Korea DMF, China DMF, Japan DMF
Mechanism of Action
"The mechanism of action of SEROQUEL is unknown. However, it has been proposed that the efficacy of SEROQUEL in schizophrenia and its mood stabilizing properties in bipolar depression and mania are mediated through a combination of dopamine type 2 (D2) and serotonin type 2 (5HT2) antagonism. Antagonism at receptors other than dopamine and 5HT2 with similar receptor affinities may explain some of the other effects of SEROQUEL. SEROQUEL’s antagonism of histamine H1 receptors may explain the somnolence observed with this drug. SEROQUEL’s antagonism of adrenergic α1 receptors may explain the orthostatic hypotension observed with this drug."
Indication
SEROQUEL is an atypical antipsychotic indicated for the treatment of:
- Schizophrenia
- Bipolar I disorder manic episodes
- Bipolar disorder, depressive episodes
Dr. Reddy's Expertise
Headquartered in Hyderabad, India, Dr. Reddy's Laboratories is one of the leading Active Pharmaceutical Ingredients (API) manufacturers and suppliers globally for Quetiapine Fumarate API. Dr. Reddy's API business is a preferred partner to pharma companies across the US, Europe, Brazil, Latin America, Japan, China, Korea, Middle East and other emerging markets.
Dr. Reddy's API business thrives on the deep technical strengths established over the last 30+ years in the development and manufacture of complex APIs such as steroids, peptides, complex long chain molecules and highly potent APIs (HPAPIs / oncology drugs). This expertise is complemented by our prowess in intellectual property and regulatory affairs which helps us consistently meet and exceed regulatory standards. Dr. Reddy's Quetiapine Fumarate API is the outcome of the extensive expertise in R&D, IP, and Regulatory.
A key component in helping our customers be first to market is a responsive supply chain. We achieve this by making sure that all our facilities are operating efficiently and to the latest standards of quality, safety, and productivity. A strong interconnect between business and factories allows for a quick reaction to dynamic market changes, so that we can avert shortages and meet sudden surges in demand.
RFQ Form
FAQs
Treats schizophrenia, bipolar disorder, and major depressive disorder
Reduces psychotic, manic, and depressive episodes
Helps restore balance of serotonin and dopamine
Avoid inhalation and skin contact
Use protective equipment
Store in a cool, dry place, away from light